Latest Updates
-
Why Women Leaders Are Crucial for Driving Change in India’s Healthcare Sector -
Who Is Bhoomika Yadav? Meet Raipur’s 19-Year-Old, Youngest Indian Model To Walk For Chanel -
Super Crispy Street Style Aloo Tikki Recipe: Your New Favorite Snack! -
Baisakhi 2026: Date, History, Rituals and Cultural Significance Explained -
At 83, Amitabh Bachchan Finds Not Working Each Day Disturbing: Why Breaking Routine Triggers Anxiety -
Alia Bhatt Serves Sharp, Subtle Drama in Gaurav Gupta’s Black Three-Piece Tuxedo -
Boss Lady By Zlaata: Workwear That Made Confidence Visible -
These 6 Seemingly Harmless Lifestyle Habits May Be Increasing Your Colorectal Cancer Risk -
World Health Day 2026: Grand Master Akshar Explains How Yoga Can Help Manage Diabetes and Hypertension -
Dal Khichdi Recipe: A Light Comfort Meal Everyone Loves
Therapeutic Target For Cancer Identified

The research team has identified seven different receptors on T cells that can suppress immune responses during a long battle with an infectious pathogen or against developing cancer. Study's lead author, E. John Wherry, Ph.D., an assistant professor in Wistar''s Immunology Program said that chronic over-stimulation of the immune system can 'exhaust' immune cells rendering them ineffective.
The key finding is that these new receptors likely control different aspects of T cell responses, such as division or expansion, controlling viral replication, and local killing of infected cells versus secretion of long-range active antiviral proteins.
"This amount of control over T cells" response is remarkable. It suggests that layers of negative regulation exist on exhausted T cells from co-expression of multiple inhibitory receptors," Nature quoted him as saying. "My bet is that these receptors inhibit different aspects of the T cells" response, but that the net result of their activation is to turn specific T cell populations off.
"We are starting to see a picture emerging of a really tuneable array of inhibitory receptors expressed on T cells. That suggests it may be possible to not only dramatically enhance antiviral or antitumor T cell responses, but also to fine tune which response you want to enhance in order to reverse T cell exhaustion and continue fighting an infection or disease.
"This presents us with a great clinical opportunity. T cells have a lot of weapons at their disposal to control viral infection and most of them are disarmed when these cells become exhausted. "It may be possible to selectively rearm T cells while generally reinvigorating them," he added.
This brings in a ray of hope in the field of cancer research, hopefully the latest findings will fetch long term results.
Disclaimer: The information provided in this article is for general informational and educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or a qualified healthcare provider with any questions you may have regarding a medical condition.



Click it and Unblock the Notifications











